Osel, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersMountain View, CA
US patents12
SAM.gov UEIR5DDHN86ANH9
CAGE code4KCX1
Incorporated inCA
- LACTIN-V
- MO-03
- clinical trials
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
12 US patents granted 2002–2025, 4 of them in the five years to SEP 2025.
Pharmaceuticals 12
- High potency stable formulations of vaginal lactobacillusUS 12,303,538 · granted MAY 20, 2025
- Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive healthUS 11,571,458 · granted FEB 7, 2023
- Use of vaginal Lactobacilli for improving the success rate of in vitro fertilizationUS 11,278,581 · granted MAR 22, 2022
- High potency stable formulations of vaginal LactobacillusUS 11,083,761 · granted AUG 10, 2021
- Transiently buffered Lactobacillus preparations and use thereofUS 8,642,029 · granted FEB 4, 2014
Newest 5 shown · Granted to Osel, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Osel, INC. | Mountain View | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.